Qi‐Man Sun

1.6k total citations
37 papers, 1.0k citations indexed

About

Qi‐Man Sun is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Qi‐Man Sun has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Qi‐Man Sun's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Qi‐Man Sun is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Qi‐Man Sun collaborates with scholars based in China, Ethiopia and Saudi Arabia. Qi‐Man Sun's co-authors include Jia Fan, Jian Zhou, Kang Song, Zheng‐Jun Zhou, Shao‐Lai Zhou, Xiaowu Huang, Yong‐Sheng Xiao, Xiutao Fu, Zhen‐Bin Ding and Zhuojun Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Qi‐Man Sun

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi‐Man Sun China 18 470 397 298 203 202 37 1.0k
Anand S. Merchant United States 18 465 1.0× 149 0.4× 327 1.1× 165 0.8× 200 1.0× 24 1.0k
Akio Saiura Japan 12 258 0.5× 111 0.3× 409 1.4× 145 0.7× 231 1.1× 38 766
Amy K. Kim United States 12 269 0.6× 237 0.6× 263 0.9× 114 0.6× 85 0.4× 28 976
Ingrid Garajová Italy 19 404 0.9× 359 0.9× 503 1.7× 59 0.3× 203 1.0× 82 1.0k
Yi‐Peng Fu China 17 205 0.4× 259 0.7× 389 1.3× 177 0.9× 180 0.9× 32 816
Sedat Karademır Türkiye 16 253 0.5× 105 0.3× 192 0.6× 55 0.3× 246 1.2× 43 731
ST Fan China 8 273 0.6× 98 0.2× 202 0.7× 97 0.5× 205 1.0× 10 799
Lijian Liang China 23 529 1.1× 325 0.8× 489 1.6× 83 0.4× 512 2.5× 74 1.4k
Zhanjun Guo China 21 903 1.9× 433 1.1× 180 0.6× 69 0.3× 84 0.4× 94 1.3k
Bijun Qiu China 12 445 0.9× 197 0.5× 185 0.6× 54 0.3× 135 0.7× 29 691

Countries citing papers authored by Qi‐Man Sun

Since Specialization
Citations

This map shows the geographic impact of Qi‐Man Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Man Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Man Sun more than expected).

Fields of papers citing papers by Qi‐Man Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi‐Man Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Man Sun. The network helps show where Qi‐Man Sun may publish in the future.

Co-authorship network of co-authors of Qi‐Man Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qi‐Man Sun. A scholar is included among the top collaborators of Qi‐Man Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi‐Man Sun. Qi‐Man Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Wei‐Guo, Jin-Feng Feng, Xian Li, et al.. (2025). MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathway. Annals of Hepatology. 30(1). 101785–101785.
2.
He, Yifeng, Xiaowu Huang, Xiaoyong Huang, et al.. (2025). Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial. Liver Transplantation. 32(2). 135–143.
3.
Zhang, Na, et al.. (2025). Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes. Diabetologia. 68(6). 1242–1260. 3 indexed citations
4.
Guo, Xiaojun, Xiaoyong Huang, Xuan Yang, et al.. (2023). Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell Death and Disease. 14(2). 79–79. 14 indexed citations
5.
Huang, Ao, De‐Zhen Guo, Ying Sun, et al.. (2023). Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer. Hepatology International. 18(1). 254–264. 7 indexed citations
6.
Luo, Chu‐Bin, Haoyang Xin, Zheng‐Jun Zhou, et al.. (2022). Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression. Hepatology. 76(4). 982–999. 78 indexed citations
7.
Hu, Bo, Xiaolu Ma, Pei‐Yao Fu, et al.. (2021). The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma. Genomics Proteomics & Bioinformatics. 19(6). 913–925. 20 indexed citations
8.
Guo, Xiaojun, Jia‐Cheng Lu, Haiying Zeng, et al.. (2021). CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma. Frontiers in Immunology. 12. 705378–705378. 26 indexed citations
9.
Hu, Jinwu, Guangyu Ding, Pei‐Yao Fu, et al.. (2020). Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis. BioMed Research International. 2020(1). 6784138–6784138. 15 indexed citations
10.
Luo, Chu‐Bin, Dan Yin, Hao Zhan, et al.. (2018). microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. Cell Death and Disease. 9(5). 535–535. 40 indexed citations
11.
Huang, Ao, Xin Zhao, Xin‐Rong Yang, et al.. (2017). Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. Journal of Hepatology. 67(2). 293–301. 81 indexed citations
12.
Zhan, Hao, Jiahao Jiang, Chu‐Bin Luo, et al.. (2016). Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance. Tumor Biology. 37(7). 9691–9698. 21 indexed citations
13.
Xue, Mengjuan, Xianying Chen, Jing Liang, et al.. (2016). Donor liver steatosis: A risk factor for early new‐onset diabetes after liver transplantation. Journal of Diabetes Investigation. 8(2). 181–187. 18 indexed citations
14.
Sun, Qi‐Man, Long-Zi Liu, Jun Zhang, et al.. (2015). High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcome. Oncology Reports. 34(2). 795–802. 8 indexed citations
15.
He, Yifeng, Chaoqun Wang, Yu Yao, et al.. (2015). Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection. PLoS ONE. 10(11). e0143657–e0143657. 20 indexed citations
16.
Fu, Xiutao, Zhi Dai, Kang Song, et al.. (2014). Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway. International Journal of Oncology. 46(2). 587–596. 192 indexed citations
17.
Sun, Qi‐Man, Chang‐Jun Tan, Min Xu, et al.. (2014). Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF-1α expression in vivo. Molecular Medicine Reports. 10(2). 585–592. 8 indexed citations
18.
Hu, Jie, Zheng Wang, Chang‐Jun Tan, et al.. (2013). Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation. Transplantation. 95(8). 991–999. 58 indexed citations
19.
Sun, Qi‐Man, Kang Song, Xizhong Shen, & Yu‐Dong Cai. (2012). The Association between KCNQ1 Gene Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis. PLoS ONE. 7(11). e48578–e48578. 33 indexed citations
20.
Xiao, Yong‐Sheng, Zhao–You Tang, Jia Fan, et al.. (2004). Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice. Journal of Cancer Research and Clinical Oncology. 130(9). 546–50. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anand S. Merchant Breakdown of academic impact, for papers by Akio Saiura Breakdown of academic impact, for papers by Amy K. Kim Breakdown of academic impact, for papers by Ingrid Garajová Breakdown of academic impact, for papers by Yi‐Peng Fu Breakdown of academic impact, for papers by Sedat Karademır Breakdown of academic impact, for papers by ST Fan Breakdown of academic impact, for papers by Lijian Liang Breakdown of academic impact, for papers by Zhanjun Guo Breakdown of academic impact, for papers by Bijun Qiu
Rankless by CCL
2026